The Patent Finder

Apexigen, Inc.

Also on record
Records under this name other than the patents Apexigen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 6 of 6 · Back to Apexigen, Inc.

PatentTitleStatus Expires Confidence
US 8,986,692Anti-VEGF Monoclonal Antibody and Pharmaceutical Composition Comprising Said Antibody
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,753,634Anti-IL-6 receptor antibodies and methods of use
Lapsed on the fee record
Ended Jun 17, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 17, 2026From the USPTO record
US 9,951,136Anti-IL-6 receptor antibodies and methods of use
Lapsed on the fee record
Ended Apr 24, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2026From the USPTO record
US 11,078,283Anti-PD-L1 antibodies and methods of use
Lapsed on the fee record
Ended Aug 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 3, 2025From the USPTO record
US 9,441,042Anti-KDR antibodies and methods of use
Lapsed on the fee record
Ended Sep 13, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 13, 2024From the USPTO record
US 9,085,621Anti-IL-1β antibodies
Lapsed on the fee record
Ended Jul 21, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 21, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited